title: Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
authors.affiliation: Hepatology & Gastroenterology, Imperial College, Norfolk Place, London W2 1NY, UK. m.thursz@imperial.ac.uk
authors.forename: Mark
authors.initials: M
authors.lastname: Thursz
authors.forename: Ashley
authors.initials: A
authors.lastname: Brown
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D005260:Female; D006513:Hepatitis B e Antigens / Q000276:immunology*; D006515:Hepatitis B virus / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000209:etiology*; D008297:Male
chemical_list: D006513:Hepatitis B e Antigens; D019259:Lamivudine